| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,010,300 | 1,429,300 | 1,313,700 | 1,434,200 | | Cost of Revenue | 65,400 | 171,100 | 317,600 | 280,500 | | | Gross Profit | 944,900 | 1,258,200 | 996,100 | 1,153,700 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 593,500 | 509,100 | 1,200,100 | 567,200 | | Non Recurring |
-
| 46,100 | (46,100) | 76,100 | | Others | 55,000 | 116,300 | 25,000 | 10,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 296,400 | 586,700 | (182,900) | 500,400 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 296,400 | 586,700 | (182,900) | 500,400 | | Interest Expense | 51,300 | 64,400 | 69,900 | 72,300 | | Income Before Tax | 245,100 | 522,300 | (252,800) | 428,100 | | Income Tax Expense | 83,300 | 180,000 | (104,500) | 212,500 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 161,800 | 342,300 | (148,300) | 215,600 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 161,800 | 342,300 | (148,300) | 215,600 | | Preferred Stock And Other Adjustments | (23,000) | (12,000) |
-
|
-
| | | Net Income Applicable To Common Shares | $138,800 | $330,300 | ($148,300) | $215,600 |
|
0.45% Nasdaq 
0.20%
Income Statement
